Blog

We wanted to reach out to you all and give some thoughts on the volatility we have experienced this week and especially during the last two trading

The week in review...Dow +914 or +2.7%, Nasdaq (210) or (1.5%), and the S&P +51 or +1.2%. While the week was dominated by more great earnings

Monday - Dow (123) to 34,077, Nasdaq (137) to 13,914 and the S&P (22) to 4,163. All three indices traded down perhaps still trying to digest

Monday - Dow +55 to 33,745, Nasdaq (50) to 13,850 and the S&P (1) to 4,127. The biggest news of the day was Microsoft's (MSFT) acquisition of

Monday - Dow +98 to 33,171, Nasdaq (79) to 13,059 and the S&P (3) to 3,974. A family office, Archegos defaulted on several margin loans over the

Monday - Dow +103 to 32,731, Nasdaq +162 to 13,377 and the S&P (+27) to 3,940. The market cheered the release of AstraZeneca's 2nd Phase III trial

Monday - Dow +175 to 32,953 (14th closing record high of 2021), Nasdaq +140 to 13,459 and the S&P +25 to 3,968 (record high). The Dow rose for a

During my days on the trading desk in San Francisco, the afternoon before a company went public was always fairly exciting; the institutional players